论文部分内容阅读
目的:临床分析妇炎康对慢性盆腔炎患者临床指标的影响作用。方法:在我院2013年5月-2014年5月实施治疗的慢性盆腔炎患者中,随机选取100例,并将其均分成两组,对照组患者实施左氧氟沙星治疗,观察组患者实施妇炎康治疗,对比分析两组患者的临床治疗效果和指标变化。结果:观察组患者的临床治疗效果明显优于对照组,差异显著,对比具有统计学意义(P<0.05);观察组患者的血清炎症因子水平变化和对照组相比,更为明显,差异显著(P<0.05)。结论:妇炎康在慢性盆腔炎患者治疗中进行应用,能够对患者的临床治疗效果和指标产生较大影响,值得推广。
Objective: To analyze the effect of Fuyankang on the clinical indexes of patients with chronic pelvic inflammatory disease. Methods: 100 cases of chronic pelvic inflammatory disease patients who were treated in our hospital from May 2013 to May 2014 were randomly divided into two groups. Patients in the control group were treated with levofloxacin, while those in the observation group were treated with Fu Yan Kang Treatment, comparative analysis of two groups of patients with clinical effects and indicators of change. Results: The clinical effect of the observation group was better than that of the control group, with significant difference (P <0.05). The changes of serum inflammatory cytokines in the observation group were more obvious than those in the control group (P <0.05). Conclusion: Fuyankang application in the treatment of patients with chronic pelvic inflammatory disease, can have a greater impact on the clinical efficacy and indicators of patients, it is worth promoting.